Swoop, a prominent provider of custom audiences for the pharmaceutical and life sciences industry, has launched the Predictive AI Adherence Targeting. This innovative targeting methodology uses machine learning and artificial intelligence to predict which patients and healthcare providers (HCPs) are likely to become non-compliant with medication regimes in the next 30 days, a challenge that costs the healthcare industry $500 billion annually. Leveraging de-identified patient data, Swoop’s technology aids in proactively addressing patient non-adherence by enabling brands to engage with patients and their HCPs before the non-adherence occurs. The method has demonstrated accurate 91% – 94% prediction rates for different conditions like type 2 diabetes, multiple sclerosis, and depression.
To read more, click here.
[Source: Business Wire, September 12th, 2023]